Fresenius Medical Valuation
| FMS Stock | USD 22.56 0.40 1.81% |
At this time, the firm appears to be overvalued. Fresenius Medical Care shows a prevailing Real Value of $20.88 per share. The current price of the firm is $22.56. Our model computes the value of Fresenius Medical Care from reviewing the firm fundamentals such as Profit Margin of 0.03 %, current valuation of 24.17 B, and Shares Outstanding of 586.83 M as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Fresenius Medical's valuation include:
Price Book 0.9157 | Enterprise Value 24.2 B | Enterprise Value Ebitda 14.0966 | Price Sales 0.6759 | Forward PE 11.3379 |
Overvalued
Today
Please note that Fresenius Medical's price fluctuation is very steady at this time. Calculation of the real value of Fresenius Medical Care is based on 3 months time horizon. Increasing Fresenius Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Fresenius stock is determined by what a typical buyer is willing to pay for full or partial control of Fresenius Medical Care. Since Fresenius Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Fresenius Stock. However, Fresenius Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 22.56 | Real 20.88 | Target 20.08 | Hype 22.52 | Naive 22.65 |
The intrinsic value of Fresenius Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Fresenius Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Fresenius Medical Care helps investors to forecast how Fresenius stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Fresenius Medical more accurately as focusing exclusively on Fresenius Medical's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Fresenius Medical's intrinsic value based on its ongoing forecasts of Fresenius Medical's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Fresenius Medical's closest peers.
Fresenius Medical Cash |
|
Fresenius Valuation Trend
Fresenius Medical's real value is important for investors to make better decisions and a more accurate overall view of Fresenius Medical's financial worth over time. Using both Fresenius Medical's enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
Fresenius Revenue by Product
Fresenius Medical Total Value Analysis
Fresenius Medical Care is currently expected to have company total value of 24.17 B with market capitalization of 13 B, debt of 12.05 B, and cash on hands of 362.77 M. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the Fresenius Medical fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
24.17 B | 13 B | 12.05 B | 362.77 M |
Fresenius Medical Investor Information
The company has price-to-book (P/B) ratio of 0.92. Some equities with similar Price to Book (P/B) outperform the market in the long run. Fresenius Medical Care has Price/Earnings To Growth (PEG) ratio of 0.45. The entity last dividend was issued on the 17th of May 2024. The firm had 2:1 split on the 4th of December 2012. Based on the analysis of Fresenius Medical's profitability, liquidity, and operating efficiency, Fresenius Medical Care may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 1.5 B | 2.6 B |
|
|
Fresenius Medical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Fresenius Medical has an asset utilization ratio of 57.33 percent. This implies that the Company is making $0.57 for each dollar of assets. An increasing asset utilization means that Fresenius Medical Care is more efficient with each dollar of assets it utilizes for everyday operations.Fresenius Medical Ownership Allocation
Fresenius Medical holds a total of 586.83 Million outstanding shares. Roughly 92.6 percent of Fresenius Medical outstanding shares are held by general public with 7.4 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Fresenius Medical Profitability Analysis
The company reported the last year's revenue of 19.45 B. Total Income to common stockholders was 732.46 M with profit before taxes, overhead, and interest of 5.31 B.Fresenius Medical Past Distributions to stockholders
About Fresenius Medical Valuation
The stock valuation mechanism determines Fresenius Medical's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Fresenius Medical Care based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Fresenius Medical. We calculate exposure to Fresenius Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Fresenius Medical's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 4.9 B | 3.7 B | |
| Pretax Profit Margin | 0.05 | 0.08 | |
| Operating Profit Margin | 0.07 | 0.13 | |
| Net Profit Margin | 0.03 | 0.05 | |
| Gross Profit Margin | 0.25 | 0.36 |
A single share of Fresenius Medical represents a small ownership stake in the entity. As a stockholder of Fresenius, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
Fresenius Medical Dividends Analysis For Valuation
Please note that Fresenius Medical has scaled down on payment of dividends at this time. Retained Earnings is likely to gain to about 11.5 B in 2024, whereas Earnings Yield is likely to drop 0.05 in 2024.
There are various types of dividends Fresenius Medical can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Fresenius shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Fresenius Medical Care directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Fresenius pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Fresenius Medical by the value of the dividends paid out.
Fresenius Medical Growth Indicators
Investing in growth stocks can be very risky. If the company such as Fresenius Medical does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 293.4 M | |
| Quarterly Earnings Growth Y O Y | 1.525 | |
| Forward Price Earnings | 11.3379 |
Fresenius Medical Current Valuation Indicators
Fresenius Medical's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Fresenius Medical's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Fresenius Medical, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Fresenius Medical's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Fresenius Medical's worth.Additional Tools for Fresenius Stock Analysis
When running Fresenius Medical's price analysis, check to measure Fresenius Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fresenius Medical is operating at the current time. Most of Fresenius Medical's value examination focuses on studying past and present price action to predict the probability of Fresenius Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fresenius Medical's price. Additionally, you may evaluate how the addition of Fresenius Medical to your portfolios can decrease your overall portfolio volatility.